Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:associated_with |
adrenal gland
|
| gptkbp:can_be_benign |
gptkb:true
|
| gptkbp:can_be_malignant |
gptkb:true
|
| gptkbp:can_be_used_to |
persistent symptoms
paroxysmal symptoms |
| gptkbp:can_cause |
anxiety
weight loss tremors pallor |
| gptkbp:can_detect |
gptkb:MRI
CT scan blood tests urine tests imaging studies biopsy |
| gptkbp:can_lead_to |
gptkb:Cardiology
stroke arrhythmias cardiovascular complications |
| gptkbp:diagnosis |
panic attacks
anxiety disorders thyroid disorders cardiac issues 24-hour urine catecholamines plasma free metanephrines |
| gptkbp:first_described_by |
gptkb:20th_century
|
| https://www.w3.org/2000/01/rdf-schema#label |
pheochromocytomas
|
| gptkbp:is_associated_with |
gptkb:neurofibromatosis_type_1
familial pheochromocytoma hereditary syndromes |
| gptkbp:occurs_in |
gptkb:children
adults any age group both sexes |
| gptkbp:originated_in |
chromaffin cells
|
| gptkbp:prevalence |
rare
|
| gptkbp:related_to |
multiple endocrine neoplasia type 2
von Hippel-Lindau syndrome |
| gptkbp:research_focus |
genetic mutations
treatment options pathophysiology |
| gptkbp:secretes |
catecholamines
|
| gptkbp:symptoms |
headache
hypertension sweating palpitations |
| gptkbp:treatment |
gptkb:pharmaceuticals
gptkb:surgery radiation therapy chemotherapy calcium channel blockers alpha blockers beta blockers |
| gptkbp:bfsParent |
gptkb:VHL
|
| gptkbp:bfsLayer |
6
|